Connors Investor Services’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,403
| Closed | -$216K | – | 157 |
|
|
2025
Q1 | $216K | Buy |
14,403
+2,843
| +25% | +$42.7K | 0.02% | 135 |
|
|
2024
Q4 | $190K | Buy |
11,560
+861
| +8% | +$14.2K | 0.02% | 147 |
|
|
2024
Q3 | $264K | Hold |
10,699
| – | – | 0.03% | 128 |
|
|
2024
Q2 | $271K | Hold |
10,699
| – | – | 0.03% | 124 |
|
|
2024
Q1 | $272K | Hold |
10,699
| – | – | 0.03% | 127 |
|
|
2023
Q4 | $242K | Hold |
10,699
| – | – | 0.03% | 127 |
|
|
2023
Q3 | $199K | Buy |
10,699
+2,500
| +30% | +$46.5K | 0.02% | 137 |
|
|
2023
Q2 | $213K | Hold |
8,199
| – | – | 0.02% | 143 |
|
|
2023
Q1 | $235K | Hold |
8,199
| – | – | 0.03% | 139 |
|
|
2022
Q4 | $243K | Buy |
+8,199
| New | +$243K | 0.03% | 130 |
|
|
2022
Q1 | – | Sell |
-7,699
| Closed | -$276K | – | 162 |
|
|
2021
Q4 | $276K | Buy |
7,699
+1,500
| +24% | +$53.8K | 0.03% | 131 |
|
|
2021
Q3 | $264K | Hold |
6,199
| – | – | 0.03% | 137 |
|
|
2021
Q2 | $268K | Buy |
6,199
+500
| +9% | +$21.6K | 0.03% | 137 |
|
|
2021
Q1 | $232K | Buy |
5,699
+1,000
| +21% | +$40.7K | 0.03% | 141 |
|
|
2020
Q4 | $213K | Buy |
+4,699
| New | +$213K | 0.03% | 131 |
|